Altace Diabetes Complications Claim May Be Discussed By Cmte.

King Pharmaceuticals' proposed claim that Altace reduces complications in diabetes patients receiving the drug to decrease cardiovascular events is likely to be a point of discussion at FDA's Cardio-Renal Drugs Advisory Committee on May 1.